MiMedx Group, Inc.
MDXG
$6.96
-$0.21-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.13% | 7.00% | 2.87% | 7.32% | 18.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.13% | 7.00% | 2.87% | 7.32% | 18.18% |
| Cost of Revenue | 27.50% | 22.16% | 3.60% | 9.36% | 4.57% |
| Gross Profit | -0.10% | 4.12% | 2.71% | 6.91% | 21.04% |
| SG&A Expenses | 8.17% | 11.32% | 3.11% | -13.73% | -0.86% |
| Depreciation & Amortization | -47.62% | 0.52% | 1.05% | -0.52% | -0.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.89% | 14.60% | 2.85% | -9.46% | -0.78% |
| Operating Income | -37.74% | -28.03% | 3.02% | 116.35% | 3,997.65% |
| Income Before Tax | -24.52% | -19.15% | 21.05% | 152.98% | 703.33% |
| Income Tax Expenses | -32.33% | 110.20% | 499.15% | 7,660.81% | 4,503.92% |
| Earnings from Continuing Operations | -22.49% | -85.50% | -10.90% | 90.48% | 566.58% |
| Earnings from Discontinued Operations | -- | -100.00% | 170.45% | 100.05% | 106.58% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.17% | -86.09% | -5.14% | 1,368.75% | 285.85% |
| EBIT | -37.74% | -28.03% | 3.02% | 116.35% | 3,997.65% |
| EBITDA | -18.14% | -13.23% | 5.41% | 110.17% | 2,292.66% |
| EPS Basic | -24.64% | -87.15% | -5.16% | 2,700.00% | 208.58% |
| Normalized Basic EPS | -33.52% | -33.79% | -1.78% | 98.99% | 633.01% |
| EPS Diluted | -22.19% | -86.13% | -9.65% | 1,358.54% | 205.15% |
| Normalized Diluted EPS | -32.84% | -19.08% | 25.38% | 149.10% | 620.39% |
| Average Basic Shares Outstanding | 0.59% | 23.16% | 26.36% | 27.15% | 27.98% |
| Average Diluted Shares Outstanding | -0.23% | 0.79% | -0.93% | 1.39% | 31.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |